Sign inSubmit
ArticleMetrics
Research Article · Open access · Published 15 March 2021

KRLSMDA: Identifying Human miRNA–Disease Association Based on Similarity and Kronecker Regularized Least Squares Method

Lingzhi Zhu1, Weimin Gao1, Guixiang Li1, Bufan Ge1, Bohan Zhang1 & Yulu Cao1

American Journal of Biochemistry and Biotechnology, Volume 17, Issue 1, pp. 76–84 · doi.org/10.3844/ajbbsp.2021.76.84

6,403 accesses3,280 downloads0 citations (Crossref)Metrics
Cite Check for updates

Abstract

A growing number of studies have suggested that miRNAs (microRNAs) have associations with human diseases, the design and discovery of drug. But so far, we do not yet fully understand the molecular mechanism of miRNAs in the development of human diseases. Predicting miRNA-disease associations is helpful for understanding the molecular mechanism of miRNAs in the development of human diseases. However, wet-lab experiments are time-consuming and need higher costs to discover miRNA-disease associations. Some computational methods are proposed for predicting miRNA-disease associations, but the prediction performance of these methods needs to be further improved. In this study, we propose a new computational model (KRLSMDA) based on similarity and the Kronecker Regularized Least Squares algorithm. In KRLSMDA, the miRNA functional similarity, the miRNA sequence similarity and the Gaussian Interaction Profile (GIP) kernel similarity are integrated into the comprehensive miRNA similarity. Then we compute the disease semantic similarity, disease functional similarity and the GIP kernel similarity to construct the comprehensive disease similarity based on the disease semantic information, the disease functional information and known miRNA-disease associations, respectively. Finally, the kronecker regularized least squares algorithm is used to predict hidden miRNA-disease associations. The experimental results show that KRLSMDA has achieved the average Area Under the Curve (AUC) values of 0.9181±0.032 and 0.9267±0.022 in 5-fold Cross-Validation (5CV) and 10-fold Cross-Validation (10CV), respectively, which demonstrates KRLSMDA is superior to four competing models. We expect KRLSMDA to be a supplement in the field of biomedical research in the future.

Licence and reuse

Open access. This article is licensed under a Creative Commons Attribution 4.0 International Licence (CC BY 4.0), as printed on the article, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original authors and the source. No permission is needed.

How to reuse this article

Responses (0)

Have a comment on this research? Sign in to respond. Responses are moderated and published with your name and affiliation; the authors are invited to reply. How we use your dataWrite a response

About this article

Cite this article

Zhu, L., Gao, W., Li, G., Ge, B., Zhang, B. & Cao, Y. (2021). KRLSMDA: Identifying Human miRNA–Disease Association Based on Similarity and Kronecker Regularized Least Squares Method. American Journal of Biochemistry and Biotechnology, 17(1), 76–84. https://doi.org/10.3844/ajbbsp.2021.76.84

Licence
CC BY 4.0
Issue
Volume 17, Issue 1
Policies
Editorial independenceUse of generative AIData availabilityAppeals and complaints
Version
Version of record
KRLSMDA: Identifying Human miRNA–Disease Association Based on Similarity and Kronecker Regularized Least Squares MethodAmerican Journal of Biochemistry and Biotechnology · Volume 17, Issue 1 · pp. 76–84 · CC BY 4.0Download